A systematic review about the role of preoperative 18F-FDG PET/CT for prognosis and risk stratification in patients with endometrial cancer

被引:0
|
作者
Noriega-Alvarez, E. [1 ,2 ]
Garcia Vicente, A. M. [1 ,3 ]
Jimenez Londono, G. A. [1 ]
Martinez Bravo, W. R. [1 ]
Gonzalez Garcia, B. [1 ]
Soriano Castrejon, A. M. [1 ]
机构
[1] Univ Hosp Ciudad Real, Dept Nucl Med, Ciudad Real, Spain
[2] EANM Inflammat & Infect Comm, SEMNIM Musculoskeletal Pathol Task Grp, Vienna, Austria
[3] SEMNIM Oncol Task Grp, Ciudad Real, Spain
关键词
Endometrial cancer; Preoperative F-18-FDG PET; SUVmax; Prognosis; Risk-stratification; Systematic review; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR VOLUME; COMPUTED-TOMOGRAPHY; FDG PET/CT; SUVMAX; LYMPHADENECTOMY; INFILTRATION; RECURRENCE; GUIDELINES; PREDICTOR;
D O I
10.1016/j.remn.2021.03.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To analyse the available literature on the prognostic value of preoperative F-18-FDG PET/CT metabolic parameters and their usefulness in risk stratification in patients with endometrial cancer (EC). Material and methods: Pubmed searches used "(endometr* OR uter*) AND (PET OR FDG)" as keywords from January-2000 to June-2020. References in included articles were checked for possible publications not included in the first search. Studies evaluating the prognostic value of preoperative F-18-FDG PET/CT and its role for risk stratification in patients with EC were included. Non-original articles (reviews, editorials, letters, legal cases, interviews, case reports, etc.) were not included. Results: Twenty-six studies (1918 patients) were selected according to the inclusion criteria in this review. Thirteen studies (939 patients) related to the prognostic role of preoperative F-18-FDG PET/CT and 14 studies (1036 patients) related to its role in risk stratification were included. Parameters such as SUVmax, metabolic tumour volume (MTV) and total lesion glycolysis (TLG) of the primary tumour were analysed. Conclusions: Preoperative SUVmax is useful for non-invasive diagnosis and for deciding the appropriate therapeutic strategy, as it could be used as an independent prognostic marker for recurrence and survival in EC. In addition, both preoperative VTM and GTL could be independent prognostic factors for predictingrecurrence and survival, but there is still insufficient scientific evidence. The usefulness of SUVmax for risk stratification is limited (there is insufficient literature that F-18-FDG PET/CT can replace surgical staging), although VTM and GTL are more accurate and have a valuable role in risk stratification of EC. However, larger multicentre studies with adequate follow-up time are needed to confirm these findings. (C) 2022 Sociedad-Espanola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 50 条
  • [1] Preoperative risk stratification using 18F-FDG PET/CT in women with endometrial cancer
    Lee, H. J.
    Ahn, B. -C.
    Hong, C. M.
    Song, B. I.
    Kim, H. W.
    Kang, S.
    Jeong, S. Y.
    Lee, S. -W.
    Lee, J.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (05): : 204 - 213
  • [2] Preoperative risk stratification using metabolic parameters of 18F-FDG PET/CT in patients with endometrial cancer
    Kitajima, Kazuhiro
    Suenaga, Yuko
    Ueno, Yoshiko
    Maeda, Tetsuo
    Ebina, Yasuhiko
    Yamada, Hideto
    Okunaga, Takashi
    Kubo, Kazuhiro
    Sofue, Keitarou
    Kanda, Tomonori
    Tamaki, Yukihisa
    Sugimura, Kazuro
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1268 - 1275
  • [3] Preoperative risk stratification using metabolic parameters of 18F-FDG PET/CT in patients with endometrial cancer
    Kazuhiro Kitajima
    Yuko Suenaga
    Yoshiko Ueno
    Tetsuo Maeda
    Yasuhiko Ebina
    Hideto Yamada
    Takashi Okunaga
    Kazuhiro Kubo
    Keitarou Sofue
    Tomonori Kanda
    Yukihisa Tamaki
    Kazuro Sugimura
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1268 - 1275
  • [4] Preoperative risk stratification of patients with endometrial cancer with F-18 FDG PET/CT
    Lee, Hong Je
    Song, Bong Il
    Kang, Sungmin
    Jeong, Shin Young
    Seo, Ji-Hyoung
    Lee, Sang-Woo
    Ahn, Byeong-Cheol
    Lee, Jaetae
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [5] 18F-FDG PET/CT in the Preoperative Staging of Endometrial Cancer
    Gutta, A.
    Pilloy, W. J.
    Mosehle, T.
    Nemutaduni, P. B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S500 - S500
  • [6] Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: A systematic review and meta-analysis
    Ayati, Narjess Khatoon
    Ghooshkhanei, Haleh
    Treglia, Giorgio
    Sabouri, Golnaz
    Davoodi, Rozita
    Sadeghi, Ramin
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [7] Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: A systematic review and meta-analysis
    Ayati, N. K.
    Sadeghi, R.
    Ghooshkhanei, H.
    Treglia, G.
    Sabouri, G.
    Davoodi, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S506 - S506
  • [8] Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: A systematic review and meta-analysis
    Ghooshkhanei, Haleh
    Treglia, Giorgio
    Sabouri, Golnaz
    Davoodi, Rozita
    Sadeghi, Ramin
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 669 - 676
  • [9] 18F-FDG PET or PET/CT role in plasmacytoma: A systematic review
    Albano, D.
    Tomasini, D.
    Bonu, M.
    Giubbini, R.
    Bertagna, F.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 39 (04): : 220 - 224
  • [10] Role of 18F-FDG PET/CT in the Preoperative Staging of Rectal Cancer
    Aroui, T.
    Testart, N.
    Rodriguez Fernandez, A.
    Sanchez Sanchez, R.
    Trivino Ibanez, E.
    Martinez Cara, J.
    Redondo Cerezo, E.
    Gomez Ro, M.
    Llamas Elvira, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S494 - S494